Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
107,228,372
-
Total 13F shares
-
53,304,185
-
Share change
-
+1,634,816
-
Total reported value
-
$743,593,762
-
Put/Call ratio
-
70%
-
Price per share
-
$13.95
-
Number of holders
-
102
-
Value change
-
+$12,202,337
-
Number of buys
-
53
-
Number of sells
-
55
Institutional Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) as of Q1 2020
As of 31 Mar 2020,
ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) was held by
102 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,304,185 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, TANG CAPITAL MANAGEMENT LLC, BlackRock Inc., PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, WESTFIELD CAPITAL MANAGEMENT CO LP, WELLINGTON MANAGEMENT GROUP LLP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Cormorant Asset Management, LP, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
102
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.